Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate plus Vitamin D3 in osteoporosis
NCT00092079Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2004
- Primary completion
- Nov 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, double-blind trial of alendronate and vitamin d in osteoporosis (2 arms), sponsored by Merck & Co. Primary endpoint: Proportion of patients who develop hypercalcuria. Started Jan 2004; status: completed.
02
Drugs
alendronatevitamin d
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00092079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092079.